Board of Directors

Deb Bremer is Vice President of Development & Medical Informatics for Pfizer, Inc. She leads a global team of professionals who provide informatics strategy and services spanning pre-clinical safety testing through all phases of drug development, regulatory submissions, external healthcare, medical affairs, and commercial therapeutic area support. Prior to joining Pfizer, Deb held positions of increasing responsibility in General Dynamics' Data Systems Division and Computer Sciences Corporation's Technology Management Group. She holds a BS in Computer Science from the State University of New York, and an MBA with a concentration in Management and Organization from the University of New Haven, Connecticut.

Sue Dubman is Senior Director of System and Data Architecture at Genzyme, serving in the role of chief data officer, and Chairperson of CRIX International�s North American Advisory Council (NAAC). Sue has more than 20 years of experience in information technology with a specialization in life sciences and healthcare. Prior to Genzyme, Sue was Vice President of Information Technology at Theravance. Before Theravance, Sue was Director of Biomedical Informatics at the NCI, where she helped lead several major programs that are widely recognized for their potential to change the way research is done, drugs are developed, and patients and providers interact with the health care enterprise. These include the Cancer Biomedical Informatics Grid or caBIG�; the joint FDA/NCI Inter-Agency Oncology Task Force initiative which become the first rendition of CRIX and included both the initial Janus (CDISC SDTM data repository) and FIREBiRD pilots; a CDISC-HL7-FDA-NCI collaboration called BRIDG; and a translational research platform (caIntegrator) to enable genomic medicine. Sue completed work towards her PhD at Brown University in population sciences and received her MA and BA from the University of Missouri.

Diana L. McKenzie is Vice President, Information Systems Infrastructure, for Amgen, Inc. Diana has responsibility for leading the global development and delivery of Amgen's Information Systems Infrastructure Services. In her role, she leads a team that plans, develops, deploys, and operates a variety of IT services. Prior to joining Amgen, Diana served for 17 years in a variety of Information Systems Leadership roles at Eli Lilly. She has chaired the PhRMA Trade Association's Information Management Leadership Committee (IMPACC), served on the PDUFA III IT FDA Advisory Committee as well as the Department of Health and Human Services Biosurveillance IT Working Group, has led the PhRMA IMPACC e-Health Futures Subcommittee, and recently joined Purdue University's School of Technology, Executive Advisory Board. She received her Bachelor of Science degree from Purdue University's School of Computer Technology in 1986 and was recognized by the university as a Distinguished Alumni in the spring of 2004.

Stephen Rosenfeld, M.D., M.B.A., is president and CEO of the Western Institutional Review Board (WIRB), the largest independent IRB in the world, with research sites in all fifty United States and more than thirty other countries. Board Certified in Internal Medicine, Dr. Rosenfeld has worked extensively with complex information technology systems in both healthcare delivery and biomedical research.

Prior to his role at WIRB, Dr. Rosenfeld was the Chief Information Officer of MaineHealth in Portland, Maine. Dr. Rosenfeld was previously employed by the National Institutes of Health (NIH) for 19 years. He joined NIH as a Clinical Associate in the National Heart, Lung and Blood Institute, and held several positions, most recently that of the Chief Information Officer and Associate Director for Clinical Research Information Systems for the NIH Clinical Center.

Dr. Rosenfeld received his bachelor's degree in physics from Yale University in New Haven, CT; his medical degree from Cornell University Medical College in New York, NY; and his masters of business administration from Georgetown University, Washington, DC. During his career he has been an active member of various committees/panels and has published numerous book chapters and articles, as well as received several honors and awards.